Letter to Shareholders from CEO Dr. Ryan Saadi Mar 6, 2026 Mar 6, 2026 Updated 38 mins ago Facebook Twitter WhatsApp SMS Email Print Copy article link Save As featured on Letter to Shareholders from CEO Dr. Ryan Saadi WARREN, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN). Facebook Twitter WhatsApp SMS Email Print Copy article link Save Sections AutomotiveBridalBusiness And CareersCommunity CaresEducationEspanolFamily LivingFashion, Beauty & FitnessFood, Recipes & EntertainingGift IdeasGreen LivingHealth & WellnessHome DecoratingHome ImprovementHot TopicsHow ToKitchen, Bed & BathLawn & GardenMoney & FinancePetsPress ReleasesReal EstateSeasonalSenior LivingSportsTech Talk & InnovationTravel
Letter to Shareholders from CEO Dr. Ryan Saadi WARREN, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN).
